Edra
European Annals of Allergy and Clinical Immunology THE OFFICIAL JOURNAL OF AAITO THE OFFICIAL JOURNAL OF SPAIC HOME PAGE
2022 Impact Factor
2.3
EDITORS IN CHIEF
M. B. Bilò (Italy)
P. Carreiro-Martins (Portugal)

DEPUTY EDITORS
R. Rodrigues Alves (Portugal)
D. Villalta (Italy)
 
ASSOCIATE EDITORS
R. Asero (Italy)
M. Branco Ferreira (Portugal)
L. Cecchi (Italy)
E. Scala (Italy)
D. Solé (Brasil)
G. Sturm (Austria)

EDITORIAL BOARD
I. Agache (Romania)
I. Annesi Maesano (France)
L. Antonicelli (Italy)
G. Azizi (Iran)
L.M. Borrego (Portugal)
K. Brockow (Germany)
S. Bavbek (Turkey)
E. Cichocka-Jarosz (Poland)
M. Cugno (Italy)
L. Delgado (Portugal)
P. Demoly (France)
G. D'Amato (Italy)
S. Durham (UK)
M. Faber (Belgium)
M. Fernandez-Rivas (Spain)
J. Fonseca (Portugal)
ZS. Gao (China)
G.P. Girolomoni (Italy)
E. Goudouris (Brasil)
A. Grumach (Brasil)
G. Kostantinou (Greece)
F. Levi-Shaffer (Israel)
M. Maurer (Germany)
L. Mayorga (Spain)
C. Micheletto (Italy)
M. Morais de Almeida (Portugal)
G. Moscato (Italy)
A. Musarra (Italy)
C. Nunes (Portugal)
M. Ollert (Lussemburgo)
P. Parronchi (Italy)
G. Passalacqua (Italy)
E. Pedro (Portugal)
A. Perino (Italy)
O. Quercia (Italy)
A. Romano (Italy)
G. Scadding (UK)
A. Todo Bom (Portugal)
A. Tedeschi (Italy)
R. van Ree (Netherland)
S. Voltolini (Italy)

FOUNDERS
F. Bonifazi (Italy)
A. Sabbah (France)
************************* 

Chief Executive Officer 
Ludovico Baldessin

Editorial Coordinator
Barbara Moret

Publishing Editor
Jessica Guenzi
j.guenzi@lswr.it

Sales
dircom@lswr.it

EDRA SpA 
Via G. Spadolini, 7
20141 Milano - Italy
Ph. 0039 (0)2-88184.1
Fax 0039 (0)2-88184.301
www.edraspa.it


Follow us on LinkedIn



European Annals of Allergy and Clinical Immunology ISSN 1764-1489

© 2024

Journals »

Volume 51 n. 5/2019
September 2019



TABLE OF CONTENTS


Reviews


» Metabolic interactions in asthma
M. Farraia mariana.farraia@gmail.com 1,2, J. Cavaleiro Rufo1, I. Paciência1,2,3, F. Castro Mendes2, L. Delgado4,5, J. Laerte Boechat6, A. Moreira1,2,7

Original Articles


» Pru p 3 sublingual immunotherapy ultra-rush protocol is safe and clinically effective
A.L. Moura al-moura@hotmail.com1, C. Pereira1,2, F.S. Regateiro1,3, J. Azevedo1, A. Todo Bom1,4, I. Carrapatoso1

» Favorable clinical efficacy of mepolizumab on the upper and lower airways in severe eosinophilic asthma: a 48-week pilot study
M. Kurosawa motohiro@kl.wind.ne.jp 1, K. Ogawa2, E. Sutoh1,2

» Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study (ÍCARA)
J. Cuesta-Herranz1, J.J. Laguna2, R. Mielgo3, I. Pérez-Camo4, A.M. Callejo5, L. Begoña leire.begona@roxall.es 6, M.C. Gomez6, B. Madariaga 6, A. Martinez6

Letter to the Editor


» Availability of epinephrine auto-injectors and knowledge of community pharmacists about their use
C. Pitsios pitsios.constantinos@ucy.ac.cy, A. Vasiliadis, K.P. Karakatsanis, R. Matzaras, T. Minasidis, A. Nteveros, G. Samanis, G. Nikolopoulos



 COMPLETE ISSUE